KMA to reiterate review on medical reform program.

Published: 2002-05-22 06:59:00

Updated: 2002-05-22 06:59:00

The KMA (President: Shin Sang-jin) resumed the general meeting of the KMA representatives on May 18, which was aborted in April 27, and strongly urged to the government for an entire review of the current medical and pharmacy role separation program. In the meeting, they made it clear that an imm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK